NCT07547501

Brief Summary

The objective of this study is to develop and validate deep learning algorithms for automated sleep stage and sub-stage classification using overnight polysomnography data. The models will be trained and evaluated on at least three independent datasets to ensure generalizability. \- Primary Outcome Measure : Accuracy of deep learning-based sleep stage classification compared to expert manual scoring (\>80% target agreement), evaluated across multiple polysomnography datasets including AP-HP (Assistance Publique - Hôpitaux de Paris) data. This is a retrospective, observational study.

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1,500

participants targeted

Target at P75+ for all trials

Timeline
9mo left

Started Jun 2026

Shorter than P25 for all trials

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 17, 2026

Completed
6 days until next milestone

First Posted

Study publicly available on registry

April 23, 2026

Completed
1 month until next milestone

Study Start

First participant enrolled

June 1, 2026

Expected
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2027

Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2027

Last Updated

April 29, 2026

Status Verified

April 1, 2026

Enrollment Period

9 months

First QC Date

April 17, 2026

Last Update Submit

April 23, 2026

Conditions

Keywords

Sleep stagingPolysomnographyEEGDeep learningArtificial intelligenceSleep disordersChronic insomniaEpilepsy

Outcome Measures

Primary Outcomes (1)

  • Prediction accuracy of sleep stages and sub-stages

    Evaluation of the deep learning model's performance in accurately classifying different sleep stages and sub-stages compared to expert manual scoring. The metrics used to characterize this outcome are the macro F1-score and/or Cohen's Kappa (κ) score, with a target prediction accuracy of \>80%. The macro F1-score measures the model's ability to correctly recognize each sleep stage while compensating for the imbalance between frequent and rare classes. Cohen's Kappa quantifies the degree of agreement between automatic predictions and human annotations by correcting for the agreement expected by chance. The combination of these two metrics offers a robust and balanced evaluation.

    Single overnight polysomnography recording per participant (duration of approximately 8 to 12 hours)

Secondary Outcomes (2)

  • Prediction accuracy of chronic insomnia profiles

    Single overnight polysomnography recording per participant (duration of approximately 8 to 12 hours)

  • Prediction accuracy of epilepsy profiles

    Single overnight polysomnography recording per participant (duration of approximately 8 to 12 hours)

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients evaluated for sleep disorders, including treatment-resistant chronic insomnia, sleep-wake rhythm disorders, chronic fatigue, and/or patients with epilepsy presenting with sleep disturbances

You may qualify if:

  • Patients with chronic insomnia and/or epilepsy who underwent polysomnography in a neurophysiology or neurology setting under the responsibility of Pr Navarro between 01 September 2011 and 31 December 2024.
  • Age ≥18 and ≤65 years at the time of the polysomnography recording.

You may not qualify if:

  • Severe psychiatric disorder, including decompensated psychotic disorder, manic episode, or major depressive episode with melancholic features.
  • Use of continuous positive airway pressure (CPAP) therapy during the night of recording.
  • Patient refusal or documented opposition to data use.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Sleep Initiation and Maintenance DisordersEpilepsySleep Wake Disorders

Condition Hierarchy (Ancestors)

Sleep Disorders, IntrinsicDyssomniasNervous System DiseasesMental DisordersBrain DiseasesCentral Nervous System DiseasesNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Olivier Pallanca, MD, PhD

    Idiap Research Institute, Switzerland

    STUDY DIRECTOR

Central Study Contacts

Vincent Navarro, MD, PhD

CONTACT

Jinmi BAEK

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 17, 2026

First Posted

April 23, 2026

Study Start (Estimated)

June 1, 2026

Primary Completion (Estimated)

March 1, 2027

Study Completion (Estimated)

March 1, 2027

Last Updated

April 29, 2026

Record last verified: 2026-04